Active Root CariesNCT01866059
Treatment of Root Caries in an Older Irish Population.
A study testing Calcium silicate cement, Glass Ionomer Cement and Resin Modified Glass Ionomer Cement in people with Active Root Caries and Over Sixty-five Years of Age, run by University College Cork at 1 site in Ireland.
Trial summary
This study will involve filling teeth which have decay on their roots with three different filling materials. Patients will attend Cork University Dental School and hospital for a clinical examination and to complete a questionnaire describing how they feel about the comfort and appearance of their teeth. Read more about this study
- Who is it for?
- Ages 65 years and olderHealthy volunteers can take part
- Conditions the study is for
- Active Root Caries, Over Sixty-five Years of Age, >=Two Carious Root Surfaces Per Patient
- What is being tested?
- Calcium silicate cement, Glass Ionomer Cement and Resin Modified Glass Ionomer Cement
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 130 participants
- Where
- 1 siteIreland
- Study dates
- Jul 2012to Dec 2018
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 65 years and older
- All sexes
- Healthy volunteers accepted
- Older adult
Who may be able to join
- At least 2 natural teeth with active root caries
- Aged 65 or older
Who cannot join
- Unable to give consent
- Edentulous
- No active carious root surfaces
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Randomised Controlled Clinical Trial to Compare Restorative Materials in the Treatment of Root Caries in an Older Irish Population.
This study will involve filling teeth which have decay on their roots with three different filling materials. Patients will attend Cork University Dental School and hospital for a clinical examination and to complete a questionnaire describing how they feel about the comfort and appearance of their teeth. Patients will be asked to provide a sample of saliva by spitting into a tube. This saliva will be tested to see what levels of bacteria are present and how well their saliva neutralises acid in their diet. This is used to assess how high or low the patient's risk of dental decay is. They will also complete a questionnaire about the amount of sugar in their diet and how often they clean their teeth. If the exam shows that any teeth are so decayed that they cannot be filled, the patient will then be offered extraction of these teeth. All treatment will be discussed with the patient. Patients will be randomly assigned one of the three materials and this material will be used for their fillings. Patients will not know which of the three materials they received but all three materials are already in use in dentistry and all of the elements of each treatment plan are well recognised, routine dental procedures. After all the treatment has been completed, each patient will be shown how best to take care of their teeth and how to manage their sugar intake to reduce their risk of further decay.
Patients will be given appointments to return for review at 6 months, 12 months, 18 months and 24 months after treatment. This will include a dental examination and dental impressions will be taken. These are used to measure how the restorative materials wear over time. Patients will also be asked to complete again the two questionnaires that they completed at their first visit to see if any of their answers have changed.
Read the detailed description
Randomized Clinical Trial This study is a prospective study of older adults. It will assess the suitability of BiodentineTM as a filling material for Class V lesions and compare it's performance to that of Glass ionomer cement (GIC) and Resin-modified glass ionomer cement (RMGIC).
Patients for the study will attend Cork University Dental School and Hospital. These patients will represent a sample of the population of elderly who are generally well and able to care for themselves independently as well as adhere to a given maintenance programme. The general methods are outlined below.
Ethical Approval Ethical approval has been obtained from the Research Ethics Committee of the Cork Teaching Hospitals (CREC) for the recruitment, sampling, and treatment of elderly patients. Written informed consent will be obtained from all participants.
Inclusion Criteria
For inclusion in this research patients will:
- Be either male or female aged 65 or over
- Present a minimum of 6 teeth in one arch
- Have sufficient manual dexterity to undertake tooth-brushing
- Have sufficient cognitive ability to understand consent procedures and be able to complete a questionnaire
Exclusion Criteria
Patients will not be eligible for inclusion if:
- They are medically frail (ASA III or IV)
- They have pulpal involvement or painful symptomology other than sensitivity
- They have severe periodontal disease
- They require antibiotic prophylaxis for invasive dental treatment
Patient Recruitment (Phase 1) Prospective patients will be approached whilst attending Cork University Dental School and Hospital. General medical and dental practitioners in Cork will also be given information regarding the study to distribute to patients that may be suitable. A number of social clubs will also be approached. They will receive all the information in writing including the inclusion criteria as well as a consent form. If they indicate a willingness to participate, they will be offered an examination appointment. Insurance will be provided under the Clinical Indemnity Scheme, University College Cork.
Clinical Examination Procedure The clinical examination procedure will determine the extent of dental disease and confirm the suitability of the patient for enrolment in the study. Clinical data will be collected by a suitably trained examiner. This examiner will also provide the restorative treatment to the patients in the study.
During the course of the initial examination the following data will be collected:
- Age
- Gender
- Number of teeth
- Visually decayed, missing and filled teeth (VDMFT) index
- Visually decayed and filled root surfaces (RDFT)
- Plaque score
- Bleeding score
- Community Periodontal Index (CPI)
- Salivary flow rate
- Salivary buffer capacity (using CRT®buffer kits)
- Strep mutans count (using CRT®bacteria kits)
- Lactobacilli count (using CRT®bacteria kits)
- Denture wearing (Acrylic/Co-Cr, age of denture, abutment teeth)
- Fluoride exposure (public/private water supply, toothpaste, mouthwash)
- Medications (xerostomic potential, sucrose containing)
- Frequency of sugar intake
- Dental attendance pattern
- Alcohol consumption
- Smoking history
- Medical History
- Radiographs (where clinically indicated) The patient will be given another appointment to return if they are accepted into the trial.
Treatment Intervention (Phase 2) Each patient will be randomly assigned (using random number allocation) to be filled with one of three filling materials; Glass Ionomer Cement (GIC), Resin Modified Glass Ionomer Cement (RMGIC) and BiodentineTM. Treatment groups will be randomized and adjusted for the covariates age, gender and caries experience. Once it has been determined which filling material is to be placed in each lesion the treatment intervention stage will proceed as follows;
- Scaling/prophylaxis to remove plaque and calculus
- Removal of carious tissue from Class V lesions with hand or rotary instruments and restoration of the resulting cavities with the randomly assigned filling material
They will then be given review appointments for 6 months, one year, 18 months and two years. They will be sent appointment cards with the date of the next appointment by post and a phone call to confirm it.
Review Appointment (Phase 3) At each review appointment the following data will be gathered;
- Survival and integrity of the restorations (according to USPHS Criteria)
- Wear rates of the restorations (by means of dental impressions and contact profilometry)
Blinding A suitably trained examiner will assess the survival and integrity of the restorations placed by the principal investigator to eliminate potential bias.
- Being tested
- Calcium silicate cement, Glass Ionomer Cement, Resin Modified Glass Ionomer Cement
- Keywords
- root caries, GIC, RMGIC, Biodentine, Calcium silicate
- Medical subject headings
- Root Caries
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Calcium silicate cementDevice
Also called Biodentine
Calcium silicate cement
Glass Ionomer CementDevice
Also called Fuji IX
Glass Ionomer Cement
Resin Modified Glass Ionomer CementDevice
Also called Fuji II LC
Resin Modified Glass Ionomer Cement
| Study group | Role | What they receive |
|---|---|---|
| Calcium silicate cement | Experimental | Biodentine Receives: Device: Calcium silicate cement |
| Glass Ionomer Cement | Active comparator | Fuji IX Receives: Device: Glass Ionomer Cement |
| Resin Modified Glass Ionomer Cement | Active comparator | Fuji II LC Receives: Device: Resin Modified Glass Ionomer Cement |
What is being measured
The primary outcome is the main question the study is designed to answer.
Survival of restorations
Restorations will be assessed by a blinded examiner to determine whether they are still in situ or whether they have been lost.
Measured: 2 year follow up
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted31 May 2013 (estimated)
- Study startJul 2012
- Primary completionDec 2016 (estimated)
- Study completionDec 2018 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Active Root CariesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Single group
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 130 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University College Cork
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Martina Hayes, University College Cork
- Investigators
- Finbarr Allen, Principal investigator, University College CorkMartina Hayes, Principal investigator, University College CorkFrank Burke, Study chair, University College Cork
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01866059
- Sponsor's protocol ID
- Root Caries Cork
- Status last verified
- May 2016
- First submitted
- 28 May 2013
- Last updated
- 11 May 2016
- Results posted
- No
- Data monitoring committee
- Yes
Publications
Hayes M, da Mata C, Tada S, Cole M, McKenna G, Burke FM, Allen PF. Evaluation of Biodentine in the Restoration of Root Caries: A Randomized Controlled Trial. JDR Clin Trans Res. 2016 Apr;1(1):51-58. doi: 10.1177/2380084416628474.
PubMed 30931695
Study at a glance
From the registry record, last updated by the sponsor on 11 May 2016. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Randomised Controlled Clinical Trial to Compare Restorative Materials in the Treatment of Root Caries in an Older Irish Population.
- ClinicalTrials.gov ID
- NCT01866059
- Acronym / sponsor ID
- Root Caries Cork
- Keywords
- root caries, GIC, RMGIC, Biodentine, Calcium silicate
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 130 participants (estimated)
- Lead sponsor
- University College CorkUniversity, hospital or other
- Study start
- Jul 2012
- Primary completion
- Dec 2016 (estimated)
- Study completion
- Dec 2018 (estimated)
- First posted
- 31 May 2013 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study will involve filling teeth which have decay on their roots with three different filling materials. Patients will attend Cork University Dental School and hospital for a clinical examination and to complete a questionnaire describing how they feel about the comfort and appearance of their teeth. Patients will be asked to provide a sample of saliva by spitting into a tube. This saliva will be tested to see what levels of bacteria are present and how well their saliva neutralises acid in their diet. This is used to assess how high or low the patient's risk of dental decay is. They will also complete a questionnaire about the amount of sugar in their diet and how often they clean their teeth. If the exam shows that any teeth are so decayed that they cannot be filled, the patient will then be offered extraction of these teeth. All treatment will be discussed with the patient. Patients will be randomly assigned one of the three materials and this material will be used for their fillings. Patients will not know which of the three materials they received but all three materials are already in use in dentistry and all of the elements of each treatment plan are well recognised, routine dental procedures. After all the treatment has been completed, each patient will be shown how best to take care of their teeth and how to manage their sugar intake to reduce their risk of further decay.
Patients will be given appointments to return for review at 6 months, 12 months, 18 months and 24 months after treatment. This will include a dental examination and dental impressions will be taken. These are used to measure how the restorative materials wear over time. Patients will also be asked to complete again the two questionnaires that they completed at their first visit to see if any of their answers have changed.
Detailed description
Randomized Clinical Trial This study is a prospective study of older adults. It will assess the suitability of BiodentineTM as a filling material for Class V lesions and compare it's performance to that of Glass ionomer cement (GIC) and Resin-modified glass ionomer cement (RMGIC).
Patients for the study will attend Cork University Dental School and Hospital. These patients will represent a sample of the population of elderly who are generally well and able to care for themselves independently as well as adhere to a given maintenance programme. The general methods are outlined below.
Ethical Approval Ethical approval has been obtained from the Research Ethics Committee of the Cork Teaching Hospitals (CREC) for the recruitment, sampling, and treatment of elderly patients. Written informed consent will be obtained from all participants.
Inclusion Criteria
For inclusion in this research patients will:
- Be either male or female aged 65 or over
- Present a minimum of 6 teeth in one arch
- Have sufficient manual dexterity to undertake tooth-brushing
- Have sufficient cognitive ability to understand consent procedures and be able to complete a questionnaire
Exclusion Criteria
Patients will not be eligible for inclusion if:
- They are medically frail (ASA III or IV)
- They have pulpal involvement or painful symptomology other than sensitivity
- They have severe periodontal disease
- They require antibiotic prophylaxis for invasive dental treatment
Patient Recruitment (Phase 1) Prospective patients will be approached whilst attending Cork University Dental School and Hospital. General medical and dental practitioners in Cork will also be given information regarding the study to distribute to patients that may be suitable. A number of social clubs will also be approached. They will receive all the information in writing including the inclusion criteria as well as a consent form. If they indicate a willingness to participate, they will be offered an examination appointment. Insurance will be provided under the Clinical Indemnity Scheme, University College Cork.
Clinical Examination Procedure The clinical examination procedure will determine the extent of dental disease and confirm the suitability of the patient for enrolment in the study. Clinical data will be collected by a suitably trained examiner. This examiner will also provide the restorative treatment to the patients in the study.
During the course of the initial examination the following data will be collected:
- Age
- Gender
- Number of teeth
- Visually decayed, missing and filled teeth (VDMFT) index
- Visually decayed and filled root surfaces (RDFT)
- Plaque score
- Bleeding score
- Community Periodontal Index (CPI)
- Salivary flow rate
- Salivary buffer capacity (using CRT®buffer kits)
- Strep mutans count (using CRT®bacteria kits)
- Lactobacilli count (using CRT®bacteria kits)
- Denture wearing (Acrylic/Co-Cr, age of denture, abutment teeth)
- Fluoride exposure (public/private water supply, toothpaste, mouthwash)
- Medications (xerostomic potential, sucrose containing)
- Frequency of sugar intake
- Dental attendance pattern
- Alcohol consumption
- Smoking history
- Medical History
- Radiographs (where clinically indicated) The patient will be given another appointment to return if they are accepted into the trial.
Treatment Intervention (Phase 2) Each patient will be randomly assigned (using random number allocation) to be filled with one of three filling materials; Glass Ionomer Cement (GIC), Resin Modified Glass Ionomer Cement (RMGIC) and BiodentineTM. Treatment groups will be randomized and adjusted for the covariates age, gender and caries experience. Once it has been determined which filling material is to be placed in each lesion the treatment intervention stage will proceed as follows;
- Scaling/prophylaxis to remove plaque and calculus
- Removal of carious tissue from Class V lesions with hand or rotary instruments and restoration of the resulting cavities with the randomly assigned filling material
They will then be given review appointments for 6 months, one year, 18 months and two years. They will be sent appointment cards with the date of the next appointment by post and a phone call to confirm it.
Review Appointment (Phase 3) At each review appointment the following data will be gathered;
- Survival and integrity of the restorations (according to USPHS Criteria)
- Wear rates of the restorations (by means of dental impressions and contact profilometry)
Blinding A suitably trained examiner will assess the survival and integrity of the restorations placed by the principal investigator to eliminate potential bias.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Single group
- Masking
- Double blind (participant, outcomes assessor)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Calcium silicate cement | Experimental | Device: Calcium silicate cementBiodentine |
| Glass Ionomer Cement | Active comparator | Device: Glass Ionomer CementFuji IX |
| Resin Modified Glass Ionomer Cement | Active comparator | Device: Resin Modified Glass Ionomer CementFuji II LC |
Who may qualify
- Ages
- 65 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Older adult
Key inclusion criteria (2 listed)
- At least 2 natural teeth with active root caries
- Aged 65 or older
Key exclusion criteria (3 listed)
- Unable to give consent
- Edentulous
- No active carious root surfaces
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Calcium silicate cementAlso: BiodentineCalcium silicate cement | Device | Calcium silicate cement |
| Glass Ionomer CementAlso: Fuji IXGlass Ionomer Cement | Device | Glass Ionomer Cement |
| Resin Modified Glass Ionomer CementAlso: Fuji II LCResin Modified Glass Ionomer Cement | Device | Resin Modified Glass Ionomer Cement |
Primary outcome
Survival of restorations
Time frame: 2 year follow up
Restorations will be assessed by a blinded examiner to determine whether they are still in situ or whether they have been lost.
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 11 May 2016.
- Derived from this study: PubMed 30931695Hayes M, da Mata C, Tada S, Cole M, McKenna G, Burke FM, Allen PF. Evaluation of Biodentine in the Restoration of Root Caries: A Randomized Controlled Trial. JDR Clin Trans Res. 2016 Apr;1(1):51-58. doi: 10.1177/2380084416628474.
Related trials for Active Root Caries
Not yet recruiting
The Efficacy of Tooth Mouse, SFD and NaF in Caries Activity in Root Caries. A Randomized Clinical Trial
Root Caries, NaF
Not yet recruitingObservational study
Surface Caries Feature Study
Caries Active, Caries Root
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Finbarr Allen principal investigator
University College Cork
Martina Hayes principal investigator
University College Cork
Frank Burke study chair
University College Cork
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Calcium silicate cement, Glass Ionomer Cement and Resin Modified Glass Ionomer Cement in people with Active Root Caries and Over Sixty-five Years of Age, run by University College Cork at 1 site in Ireland.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 11 May 2016. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Ireland. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Survival of restorations (time frame: 2 year follow up). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT01866059, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 May 2016.